Buy & Sell AST SpaceMobile Inc (ASTS) – AST SpaceMobile Inc Price Today
Aura AI Summary
Key Stats
- $21.35BMarket Cap
- MediaSector
- -50.7%3M Drawdown
- $21.31BEnterprise Value
- -Dividend Yield
- 26 daysTypical Hold Time
AST SpaceMobile Inc (ASTS) is currently valued at a market capitalization of $21.35B, with an enterprise value of $21.31B. Over the past 52 weeks, AST SpaceMobile Inc has traded between a low of $36.91 and a high of $133.09, highlighting its annual price range. Over the past three months, AST SpaceMobile Inc has recorded a drawdown of -50.7%, reflecting recent price volatility. On average, investors hold AST SpaceMobile Inc for approximately 26 days, indicating typical investor behavior on the platform.
About AST SpaceMobile Inc
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building the global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio. AST is on a mission to eliminate the connectivity gaps faced by mobile subscribers and finally bring broadband to the billions who remain unconnected.
Most Recent News
Exosens wins contract to supply 17,000 night vision tubes to Czech Armed Forces through 2032
Exosens has secured a long-term contract with BROLIS to supply approximately 17,000 high-performance image intensifier tubes for the Czech Armed Forces through 2032. This is the largest procurement of such tubes by the Czech Republic, highlighting th...

Global LED packaging market to reach $27.21B by 2035, driven by energy-efficient lighting and smart tech growth.
The global LED packaging market, valued at $17.56 billion in 2025, is projected to grow to $27.21 billion by 2035 with a CAGR of 4.5%. Growth is fueled by rising demand for energy-efficient lighting, smart infrastructure, and advanced automotive ligh...

CHMP gives positive opinion for Hopledo® to treat Parkinson's motor fluctuations in Europe
The European CHMP has recommended approval of Hopledo® (IPX203), a modified-release levodopa/carbidopa treatment for adults with Parkinson’s disease experiencing moderate to severe motor fluctuations. Based on Phase 3 RISE-PD trial data, Hopledo® sho...
